Vyome Holdings, Inc SEC filings HIND
Vyome Holdings, Inc has 693 filings in SEC EDGAR's recent list, going back to Feb 13, 2008. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 28, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Mar 31, 2026 | Apr 24, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2026 | Mar 20, 2026 |
| DEF 14A | Proxy statement | Oct 6, 2025 | Oct 28, 2025 |
| DEF 14A | Proxy statement | Mar 14, 2025 | Apr 1, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 3, 2025 | Mar 3, 2025 |
| DEF 14A | Proxy statement | Jan 24, 2024 | Feb 23, 2024 |
| PRE 14A | Preliminary proxy statement | Jan 5, 2024 | Jan 5, 2024 |
| DEF 14A | Proxy statement | Nov 10, 2022 | Dec 14, 2022 |
| PRE 14A | Preliminary proxy statement | Oct 31, 2022 | Dec 14, 2022 |
| DEFA14A | Additional proxy material | Sep 1, 2020 | — |
| DEF 14A | Proxy statement | Aug 7, 2020 | Sep 16, 2020 |
| DEFA14A | Additional proxy material | Jun 13, 2019 | — |
| DEF 14A | Proxy statement | Jun 13, 2019 | Jul 23, 2019 |
| PRE 14A | Preliminary proxy statement | May 31, 2019 | Jul 23, 2019 |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 13, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2018 | Jun 13, 2018 |
| DEFA14A | Additional proxy material | Apr 27, 2017 | — |
| DEF 14A | Proxy statement | Apr 27, 2017 | Jun 6, 2017 |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HIND (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Clemente, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1427570
- Former names
- ReShape Lifesciences Inc. (until Aug 14, 2025); OBALON THERAPEUTICS INC (until Jun 21, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.